Supriya Lifescience Ltd
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.
05:37 PM, 2nd Feb 2026
Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Monday February 09 2026 inter alia to Consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025. This is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives is closed from January 01 2026 till 48 hours after declaration of Unaudited Financial Results on February 09 2026.Kindly take the above information on your records.